.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Radiation Oncology Advances
. Ed(S): Mehta, Minesh P. (University Of Wisconsin Hospital Medical School); Bentzen, Soren M.; Tome, Wolfgang; Harari, Paul M.; Mackie, T. Rockwell
€ 196.05
FREE Delivery in Ireland
Description for Radiation Oncology Advances
Hardback. Presents a comprehensive overview of the developments shaping the practice of radiation oncology. This title covers advances in treatment planning and delivery, in biological targeted therapies combined with radiation and in functional and molecular imaging. Editor(s): Mehta, Minesh P. (University of Wisconsin Hospital Medical School); Bentzen, Soren M.; Tome, Wolfgang; Harari, Paul M.; Mackie, T. Rockwell. Series: Cancer Treatment and Research. Num Pages: 336 pages, biography. BIC Classification: MJCL; MMPH. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 25. Weight in Grams: 754.
from combining radiation with a molecular targeted agent – namely cetuximab, a recombinant mouse/human chimeric monoclonal antibody against the Epidermal Growth Factor (EGF) receptor [4] Astsaturov, Cohen and Harari present a more indepth review of the biology of the EGF Receptor and its signaling pathway in Chap. 7 as a potential target in combination with fractionated radiotherap y for head and neck squamous cell carcinoma (HNSCC). A flurry of agents are under de velopment for targeting EGFR and in March 2006, the US Food and Drugs Administration approved cetuximab combined with radiation as a primary treatment option for patients with ... Read more
from combining radiation with a molecular targeted agent – namely cetuximab, a recombinant mouse/human chimeric monoclonal antibody against the Epidermal Growth Factor (EGF) receptor [4] Astsaturov, Cohen and Harari present a more indepth review of the biology of the EGF Receptor and its signaling pathway in Chap. 7 as a potential target in combination with fractionated radiotherap y for head and neck squamous cell carcinoma (HNSCC). A flurry of agents are under de velopment for targeting EGFR and in March 2006, the US Food and Drugs Administration approved cetuximab combined with radiation as a primary treatment option for patients with ... Read more
Product Details
Format
Hardback
Publication date
2007
Publisher
Springer-Verlag New York Inc. United States
Number of pages
336
Condition
New
Series
Cancer Treatment and Research
Number of Pages
336
Place of Publication
New York, NY, United States
ISBN
9780387367439
SKU
V9780387367439
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
Reviews for Radiation Oncology Advances
From the reviews: "Major advances in radiation oncology ... are reviewed in this book. ... Resident, attending and practicing radiation oncologists are the intended audience. The authors are respected radiation oncology practitioners and researchers. ... This excellent account of the major recent advances in radiation oncology is well written and edited. ... It is useful for both practicing ... Read more